Search Results - "vitiligo"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Vitiligo: symptoms, pathogenesis and treatment by Ghafourian, E., Ghafourian, Sobhan, Sadeghifard, Nourkhoda, Mohebi, Reza, Shokoohini, Y., Nezamoleslami, S., Hamat, Rukman Awang

    Published 2014
    “…Vitiligo is an acquired cutaneous disorder of pigmentation, with an incidence of 0.5% to 2% worldwide. …”
    Get full text
  3. 3

    Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of Vitiligo treatment success by Batchelor, J.M., Tan, Wei, Tour, S., Yong, A., Montgomery, Alan A., Thomas, K.S.

    Published 2016
    “…Background: Patient-reported outcome measures are rarely used in vitiligo trials. The Vitiligo Noticeability Scale (VNS) is a new patient-reported outcome measure assessing how ‘noticeable’ the vitiligo patches are after treatment. …”
    Get full text
  4. 4
  5. 5

    Setting priorities and reducing uncertainties for the treatment of vitiligo by Eleftheriadou, Viktoria

    Published 2013
    “…Vitiligo is the most common skin disorder resulting in depigmentation, but high-quality research is lacking. …”
    Get full text
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Independent component analysis for assessing therapeutic response in vitiligo skin disorder by M.H.A., Fadzil, S., Norashikin, H.H., Suraiya, H., Nugroho

    Published 2009
    “…This paper describes an image analysis technique that objectively measures skin repigmentation for the assessment of therapeutic response in vitiligo treatments. Skin pigment disorders due to the abnormality of melanin production, such as vitiligo, cause irregular pale patches of skin. …”
    Get full text
    Get full text
  11. 11

    Quality of life in people with vitiligo: a systematic review and meta-analysis by Morrison, B., Burden-Teh, Esther, Batchelor, Jonathan M., Mead, E., Grindlay, Douglas, Ratib, Sonia

    Published 2018
    “…Previous studies suggest a reduction in quality of life (QoL) due to vitiligo, but to date no systematic review has quantified this in comparison to people without vitiligo. …”
    Get full text
  12. 12
  13. 13

    Objective assessment of vitiligo with a computerised digital imaging analysis system by Shamsudin, Norashikin, Hussein, Suraiya, Nugroho, Hermawan, Ahmad Fadzil, Mohd Hani

    Published 2015
    “…An objective tool to quantify treatment response in vitiligo is currently lacking. This study aimed to objectively evaluate the treatment response in vitiligo by using a computerised digital imaging analysis system (C-DIAS) and to compare it with the physician's global assessment (PGA). …”
    Get full text
    Get full text
  14. 14

    Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis by Ban, Lu, Labbouz, S., Grindlay, Douglas J.C., Batchelor, Jonathan M., Ratib, Sonia

    Published 2018
    “…Vitiligo is a chronic disorder causing skin depigmentation with around 1% global prevalence, affecting people of all ages, skin types and genders.1 Due to the absence of melanin in lesional skin there is a theoretical concern that there might be a higher risk of skin cancer in people with vitiligo. …”
    Get full text
  15. 15

    The prevalence of psychological co-morbidity in people with vitiligo: a systematic review and meta-analysis by Osinubi, O., Grainge, Matthew J., Ahmed, A., Batchelor, Jonathan M., Grindlay, Douglas, Thompson, A.R., Ratib, Sonia

    Published 2018
    “…Background: Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0.2 to 1.8%. …”
    Get full text
  16. 16

    Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas by Nugroho, Hermawan, Mohd Hani, Ahmad Fadzil, Shamsudin, Norashikin, Hussein, Suraiya Hani

    Published 2013
    “…Background: Vitiligo is a cutaneous pigmentary disorder characterized by depigmented macules and patches that result from loss of epidermal melanocytes. …”
    Get full text
    Get full text
  17. 17

    Assessment of therapeutic response in skin pigment disorder treatment by M.H.A., Fadzil, H., Nugroho, S., Norashikin, H.H., Suraiya

    Published 2008
    “…This paper describes an image analysis technique that objectively measure skin repigmentation for the assessment of therapeutic response in vitiligo treatments. Skin pigment disorders due to the abnormality of melanin production such as vitiligo, cause irregular pale patches of skin. …”
    Get full text
    Get full text
  18. 18
  19. 19

    Antinuclear antibodies in non-systemic autoimmune rheumatic disease dermatological conditions by Mahayidin, Hasni, Bakrin, Ikmal Hisyam

    Published 2021
    “…This review summarises the available studies on ANA IFA in non-SARD dermatological conditions which include atopic dermatitis (AD), psoriasis, vitiligo and autoimmune bullous diseases. It aims to determine the prevalence of ANA, the commonly reported ANA titres and patterns, as well as any clinical associations between ANA and non-SARD dermatological conditions.…”
    Get full text
  20. 20